Return on equity (ROE) is the profit a company earns for every dollar of shareholder money invested in it, shown as a percentage. It is net income divided by shareholder equity, and the table shows both amounts: the profit earned and the equity it was earned on. A higher ROE means more profit per dollar of equity, but ROE also rises when equity shrinks through buybacks, dividends or losses, and it has no meaning for a company with negative equity. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
Replimune Group, Inc. roe for the quarter ending 2026-06-30 was -281.14%, a change of -197.92% year-over-year.
Replimune Group, Inc. roe for the quarter ending 2026-03-31 was -188.94%, a change of -129.47% year-over-year.
Replimune Group, Inc. roe for the quarter ending 2025-12-31 was -149.55%, a change of -102.23% year-over-year.
Replimune Group, Inc. roe for the quarter ending 2025-09-30 was -117.82%, a change of -61.98% year-over-year.
Replimune Group, Inc. roe for fiscal 2026 was -188.94%, a change of -129.47% from fiscal 2025.
Replimune Group, Inc. roe for fiscal 2025 was -59.47%, a change of -1.85% from fiscal 2024.
Replimune Group, Inc. roe for fiscal 2024 was -57.62%, a change of -26.23% from fiscal 2023.
Replimune Group, Inc. roe for fiscal 2023 was -31.39%, a change of -2.68% from fiscal 2022.